Order Article Reprints

Senyurek S, Aygun MS, Kilic Durankus N, Akdemir EY, Sezen D, Topkan E, Bolukbasi Y, Selek U. The Systemic Inflammation Response Index Efficiently Discriminates between the Failure Patterns of Patients with Isocitrate Dehydrogenase Wild-Type Glioblastoma Following Radiochemotherapy with FLAIR-Based Gross Tumor Volume Delineation. Brain Sciences. 2024; 14(9):922. https://doi.org/10.3390/brainsci14090922

Senyurek, Sukran, Murat Serhat Aygun, Nulifer Kilic Durankus, Eyub Yasar Akdemir, Duygu Sezen, Erkan Topkan, Yasemin Bolukbasi, and Ugur Selek. 2024. "The Systemic Inflammation Response Index Efficiently Discriminates between the Failure Patterns of Patients with Isocitrate Dehydrogenase Wild-Type Glioblastoma Following Radiochemotherapy with FLAIR-Based Gross Tumor Volume Delineation" Brain Sciences 14, no. 9: 922. https://doi.org/10.3390/brainsci14090922

Senyurek, S., Aygun, M. S., Kilic Durankus, N., Akdemir, E. Y., Sezen, D., Topkan, E., Bolukbasi, Y., & Selek, U. (2024). The Systemic Inflammation Response Index Efficiently Discriminates between the Failure Patterns of Patients with Isocitrate Dehydrogenase Wild-Type Glioblastoma Following Radiochemotherapy with FLAIR-Based Gross Tumor Volume Delineation. Brain Sciences, 14(9), 922. https://doi.org/10.3390/brainsci14090922